1. Home/
  2. Compounds/
  3. erlotinib:PLX-4032 (2:1 mol/mol)

erlotinib:PLX-4032 (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2erlotinib:PLX-4032 (2:1 mol/mol)
PharmacoGx erlotinib:PLX-4032 (2:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to erlotinib:PLX-4032 (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA OVOL3 CTRPv2 pan-cancer AAC -0.087 0.02
mRNA NADK CTRPv2 pan-cancer AAC -0.095 0.02
mRNA MFRP CTRPv2 pan-cancer AAC -0.093 0.02
mRNA KCTD19 CTRPv2 pan-cancer AAC -0.087 0.02
mRNA GBF1 CTRPv2 pan-cancer AAC -0.088 0.02
mRNA POLR1C CTRPv2 pan-cancer AAC -0.089 0.02
mRNA MAP2K2 CTRPv2 pan-cancer AAC -0.091 0.02
mRNA NEDD4 CTRPv2 pan-cancer AAC 0.093 0.02
mRNA NUDT21 CTRPv2 pan-cancer AAC -0.092 0.02
mRNA CSPG4 CTRPv2 pan-cancer AAC 0.1 0.02
Download CSV